A comparison of arterial versus venous-activated clotting time in patients with congenital heart disease undergoing cardiac catheterization

Catheterization and Cardiovascular Interventions

Volumn 46, Issue 2, 1999, Pages 194-196

  Zeevi, Benjamin ^a   Bar Mor, Galit ^a   Livne, Michal ^a   Berant, Michael ^a  

^a NONE

Author keywords

Activated clotting time; Cardiac catheterization; Congenital heart disease

Indexed keywords

HEPARIN;

ADOLESCENT; ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CHILD; CONGENITAL HEART DISEASE; CYANOSIS; DOSE RESPONSE; FEMALE; HEART CATHETERIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY;

EID: 0032951974     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/(SICI)1522-726X(199902)46:2<194::AID-CCD16>3.0.CO;2-M     Document Type: Article

References (10)

1. Freed MD, Keane JF, Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation 1974;50:565-569.
2. Girod DA, Hurwitz RA, Caldwell RL. Heparinization for prevention of thrombosis following pediatric percutaneous arterial catheterization. Pediatr Cardiol 1982;3:175-180.
3. Grady RM, Eisenberg PR, Bridges ND. Rational approach to use heparin during cardiac catheterization in children. J Am Coll Cardiol 1995;25:725-729.
4. Rath B, Bennett DH. Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angiography. Br Heart J 1990;63:18-21.
5. Warner MF, Mian MS, Missri JC. Activated clotting-time variability in patients undergoing coronary angioplasty. Clin Cardiol 1994;17:372-374.
6. Pesola GR, Johnson A, Pesola DA. Percutaneous transluminal coronary angioplasty: comparison of arterial vs. venous activated clotting time. Cath Cardiovasc Diagn 1996;37:140-144.
7. Prieto LR, Foreman CK, Cheatham JP, Latson LA. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard clamshell septal umbrella. Am J Cardiol 1996;77:1310-1312.
8. Hausdorf G, Schneider M, Franzbach B. Transcatheter closure of secundum atrial septal defects with the atrial septal defect occlusion System (ASDOS): initial experience in children. Heart 1996;75:83-88.
9. Avendano A, Ferguson JJ. Comparison of Hemochron and Hemo Tec activated coagulation time target values during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994;23:907-910.
10. Klein LW, Agarwal JB. When we "act" on ACT levels: activated clotting time measurements to guide heparin administration during and after interventional procedures. Cath Cardiovasc Diagn 1996; 37:154-157.